June 12, 2019 — Amgen is committed to serving patients with innovative medicines to treat serious diseases. In pursuit of this core mission, we have grown over time from a company with a handful of medicines treating hundreds of thousands of patients largely in the U.S. to a company with 20 medicines treating millions of patients in approximately 100 countries around the world.
From a clever way to help prep kids for surgery to a baby bottle nipple shaped just like Mom's, these nurses' bright ideas helped them win Johnson & Johnson's first nursing innovation challenge—and a total of $100,000 in grant money.
Blog
By Meghan Rabbitt
When you think about groundbreaking healthcare innovations—creations that forever changed how medicine is practiced, like the invention of sutures—chances are you first think of medical device engineers and pharmaceutical scientists brainstorming in a lab.
May 14, 2019—For the third year, Sanofi has published its Integrated Report, "Our Responsibility for the Future”.
This year, the report took on a shorter, bolder format. In this latest edition, we illustrate our commitments and long-term value creation for all stakeholders, giving them a clear, concise, and comprehensive vision of our business model. We also provide key information about the company, its strategy, its value creation, and its sustainable governance, as well as its financial and non-financial performance.
Omar Ishrak participates in Business Roundtable #EmbracingSustainability campaign, challenging America's top CEOs to share how they are advancing sustainability
Summary:
Business Roundtable CEOs, including Medtronic Chairman and CEO, Omar Ishrak, are embracing sustainability across their businesses. Now, through the #EmbracingSustainability challenge, they are sharing progress and calling on other business leaders to balance environmental stewardship practices and social impact with economic growth for a sustainable future.
Article
Business Roundtable CEOs, including Medtronic Chairman and CEO, Omar Ishrak, are embracing sustainability across their businesses. Now, through the #EmbracingSustainability challenge, they are sharing progress and calling on other business leaders to balance environmental stewardship practices and social impact with economic growth for a sustainable future.
A particular strain of the bacteria can be deadly for those over the age of 60—and it's not the kind that causes food poisoning. But this Janssen researcher is committed to finding a preventive treatment.
Blog
By Jessica Brown
Think of "E. coli," and you probably picture outbreaks of foodborne illnesses that can cause severe stomach cramps, vomiting and more. After all, certain strains of the bacterium are among the most common and potentially lethal causes of food poisoning.
They're the winners of the second annual Johnson & Johnson WiSTEM2D Scholars Award, thanks to such amazing innovations as tattoos that can monitor changes in your metabolism. Meet them and their groundbreaking work.
Article
A better, smarter 3-D printer. A gel that could speed up wound healing—and minimize scarring. Tattoos that could monitor your metabolism.
These are just a sampling of the big ideas the winners of Johnson & Johnson’s second annual WiSTEM2D Scholars Award Program are hoping to one day bring to market.
LEVERKUSEN, Germany, April 18, 2019 /3BL Media/ – Bayer’s Board of Management has appointed Dr. Monika Lessl as Bayer Foundations’ executive committee member to lead both the Bayer Science Foundation and the Bayer Cares Foundation. This role will be integrated into her current leadership of Bayer’s Corporate Innovation and R&D function.
Millions of people in developing countries have no access to medicines. In some cases they cannot afford them, while in others there simply are no markets and no functioning healthcare system. We are working to provide help in a number of ways. With our contraception access programs, for example, we aim to make self-determined family planning available to women in order to reduce maternal and infant mortality.
More than 220 cattle professionals engage over key topics of parasite control, bovine respiratory disease, reproduction, digital innovation and well-being at the 2nd Bayer International Beef Symposium
Press Release
MONHEIM, Germany & RIBEIRÃO PRETO, Brazil, April 10, 2019 /3BL Media/ –Bayer brought together global thought leaders in beef cattle health and management to share the latest in research and innovation at its 2nd International Beef Symposium in Ribeirão Preto, Brazil from 31st March to 2nd April.
Study is planned to assess efficacy and safety of Entresto® (sacubitril / valsartan) vs enalapril in 900 patients with chronic Chagas cardiomyopathy; recruitment is planned to commence within 2019
Chagas disease is a potentially life-threatening neglected disease, affecting approximately six million people worldwide1,2, mostly in Latin America; up to 30% of chronically infected people develop cardiac disorders3
Chagas cardiomyopathy is the most important clinical manifestation of the disease, resulting in the majority of morbidity and mortality4
The Global Chagas Disease Coalition is a collaborative alliance, which aims to increase awareness of Chagas disease and foster synergies in controlling the disease and promoting access to diagnosis and treatment5
Press Release
Study is planned to assess efficacy and safety of Entresto® (sacubitril / valsartan) vs enalapril in 900 patients with chronic Chagas cardiomyopathy; recruitment is planned to commence within 2019
Chagas disease is a potentially life-threatening neglected disease, affecting approximately six million people worldwide1,2, mostly in Latin America; up to 30% of chronically infected people develop cardiac disorders3
Chagas cardiomyopathy is the most important clinical manifestation of the disease, resulting in the majority of morbidity and mortality4
The Global Chagas Disease Coalition is a collaborative alliance, which aims to increase awareness of Chagas disease and foster synergies in controlling the disease and promoting access to diagnosis and treatment5
